8-K/A
filed February 6, 2024, 6:59 PM ET
ticker GEHC
CIK 0001932393
earnings
confidence high
sentiment positive
materiality 0.80
GE HealthCare Q4 rev $5.2B (+5% organic), adj EPS $1.18; FY2024 adj EPS guide $4.20-$4.35
GE HealthCare Technologies Inc.
2023-FY EPS reported
$3.03
revenue$19,552,000,000
- Q4 revenue $5.2B, up 5% organic YoY; net income $403M ($0.88 EPS) vs $554M ($1.21) prior year.
- Adjusted EBIT margin 16.1% in Q4, flat vs standalone prior year; full year adj EBIT margin 15.1% vs 14.5% standalone prior year.
- Full year revenue $19.6B (+7% reported, +8% organic); orders book-to-bill 1.03x.
- 2024 guidance: organic rev growth ~4%, adj EBIT margin 15.6%-15.9%, adj EPS $4.20-$4.35, FCF ~$1.8B.
- Repaid $850M debt in Q4, $150M in Jan 2024; announced agreement to acquire MIM Software (no value disclosed).
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
GE HealthCare Technologies Inc. reported fourth quarter ended December 31, 2023 results: revenue $5.2 billion, net income $403 million, EPS $0.88.
- Period
- fourth quarter ended December 31, 2023
- Revenue
- $5.2 billion
- Net income
- $403 million
- EPS
- $0.88
- Result
- reported results
Exact text from the filing
growth. We’re confident heading into 2024 amid the backdrop of an improved capital equipment landscape.” Fourth Quarter 2023 Total Company Financial Performance • Revenues of $5.2 billion increased 5% on both a reported and Organic* basis year-over-year, driven by price and volume. • Total company book-to-bill was strong at 1.05 times, defined as Total orders
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
GE HealthCare Technologies Inc. reported the fiscal year ended December 31, 2023 results: revenue $19.6 billion, net income $1.6 billion, EPS $3.04. Guidance reaffirmed.
- Period
- the fiscal year ended December 31, 2023
- Revenue
- $19.6 billion
- Net income
- $1.6 billion
- EPS
- $3.04
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
million versus $109 million for the prior year. • Segment EBIT margin was 24.4% versus 23.0% for the prior year. Full Year 2023 Total Company Financial Performance • Revenues of $19.6 billion increased 7% year-over-year and 8% on an Organic* basis with growth across all segments and regions. • Total company book-to-bill was 1.03 times, as orders dollars outpaced
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.